Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX)

Historical Holders from Q1 2014 to Q3 2025

Symbol
AXDX on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
27.8M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-1
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Indaba Capital Management, L.P. 9.9% $2.15M 2.75M Indaba Capital Management, L.P. 04 Feb 2025

Institutional Holders of Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 0 $0 -$2.08K 0
2025 Q2 325K $2.08K $0.01 1
2025 Q1 325K $228K $0.70 1
2024 Q4 325K $390K $1.20 1
2024 Q3 325K $556K $1.71 1
2024 Q2 325K $381K $1.17 1
2024 Q1 325K $322K -$171K $0.99 1
2023 Q4 294K $1.15M -$24.6K $3.92 2
2023 Q3 292K $1.68M -$27.3M $5.75 2
2023 Q2 22.1M $17.9M -$1.7M $0.81 48
2023 Q1 24.5M $17.1M -$735K $0.70 64
2022 Q4 25.5M $18M -$2.31M $0.71 70
2022 Q3 27.1M $41.2M +$13M $1.52 74
2022 Q2 18.7M $18.6M -$4.85M $0.99 65
2022 Q1 22.7M $32.6M -$3.08M $1.44 92
2021 Q4 23.9M $125M +$1.06M $5.22 101
2021 Q3 23.1M $135M -$6.51M $5.83 101
2021 Q2 24.2M $195M -$4.13M $8.06 91
2021 Q1 24.7M $205M -$24.7M $8.32 97
2020 Q4 27.8M $211M -$14.7M $7.58 111
2020 Q3 29.2M $311M -$5.07M $10.66 111
2020 Q2 29.5M $448M +$4.13M $15.16 119
2020 Q1 29.5M $246M -$8.84M $8.33 104
2019 Q4 30.3M $513M +$10.4M $16.90 104
2019 Q3 29.7M $551M -$3.17M $18.57 111
2019 Q2 29.7M $679M +$50.9M $22.88 115
2019 Q1 27.5M $579M +$584K $21.02 112
2018 Q4 27.7M $318M +$10.1M $11.50 104
2018 Q3 26.7M $612M +$44.7M $22.95 116
2018 Q2 24.7M $551M +$80.3M $22.30 115
2018 Q1 21.2M $484M +$380K $22.85 115
2017 Q4 20.7M $544M -$29.7M $26.20 113
2017 Q3 22.2M $499M +$42.8M $22.45 116
2017 Q2 20.2M $554M +$12.7M $27.35 116
2017 Q1 20.3M $493M +$161M $24.20 96
2016 Q4 15.3M $317M +$15.9M $20.75 106
2016 Q3 14.4M $393M +$29.3M $27.26 99
2016 Q2 13.6M $196M -$4.16M $14.39 93
2016 Q1 13.8M $198M -$7.75M $14.37 90
2015 Q4 13.6M $292M +$71M $21.49 94
2015 Q3 10.4M $168M +$102K $16.18 86
2015 Q2 10.1M $260M +$36.1M $25.81 84
2015 Q1 8.67M $195M +$18.6M $22.50 72
2014 Q4 7.9M $152M +$12.3M $19.19 76
2014 Q3 5.38M $115M +$11.5M $21.48 69
2014 Q2 4.8M $125M -$83.3M $26.00 73
2014 Q1 8.87M $193M +$113M $21.81 55